Healthcare and Life Science
Early skeleton map reveals how bones form in humans
The first ‘blueprint’ of human skeletal development reveals how the skeleton forms, shedding light on the process of arthritis, and highlighting cells involved in conditions that affect skull and bone growth. ...
Appointment of new Vice President of Sales and Marketing at Lucida Medical
We are pleased to announce the appointment of Corina Cucuruzac as Vice President of Sales and Marketing at Lucida Medical, effective immediately. With a distinguished career in the MedTech industry across various fields, Corina brings deep expertise in driving growth, building strong cu...
Drive business success with Best Employers Eastern Region 2025
Best Employers has been changing the face of employee engagement since 2012, by helping organisations get a deeper understanding of their employees through a detailed engagement survey. Personalised results and tailored action plans then help them evolve their workplaces for the better....
Babraham Research Campus’ £3.15bn life science ecosystem soars
New report reveals how groundbreaking research at the Campus is delivering major gains for UK economic growth and job creation. ...
Could new implants treat depression, dementia and chronic pain?
Janine Machin, Technology correspondent, BBC News writes: Tiny electronic implants have already transformed the lives of hundreds of thousands of people in the UK, from pacemakers that control heart conditions to cochlear implants that improve hearing.Now a partnership of peo...
Cambridge on song as ARIA orchestrates brain health revolution
Tony Quested, Business Weekly writes: A large cohort spanning the Cambridge life sciences, technology and business worlds has announced a multi-million-pound, three-year collaboration with the Advanced Research and Invention Agency (ARIA), the UK Government’s new research funding agency...
Targeting IL-23, Medicilon assists the development of a variety of new drugs for Psoriasis
With people’s in-depth understanding of the inflammatory pathways of psoriasis, biologics continue to develop. From tumor necrosis factor alpha (TNF-α), to IL-17 inhibitors, and then to IL-23 inhibitors, biologics have brought new light to the treatment of psoriasis again. In recent y...
Medicilon neural system disease models help our clients advance novel drug development
Medicilon Pharmacodynamics Department can deliver multiple nervous system models based on anti-depressants, anti-Alzheimer's drugs, sedative-hypnotic and anti-anxiety drugs, analgesics, anti-convulsant, anti-Parkinson's drugs, and anti-schizophrenia drugs. Those models can effectively e...
impulse 2025 - the entrepreneurship programme for innovators is now open for applications
impulse is an action-learning programme designed to catalyse the development of high-potential innovation into commercial propositions, guided by experienced entrepreneurs and mentors from the Cambridge innovation cluster. The 3-month hybrid programme – which runs from 29...
Tristan backs £300m+ life sciences platform
Tristan Capital Partners’ debt fund has refinanced a £310m prime life science portfolio located across Cambridge and Oxford, Green Street News can reveal. ...